NCT07625735

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-07-01Est. Completion: 2026-11-30

Enrollment target: 3,000 participants

Contact

HER2-positive Gastric CancerGastroesophageal Junction Adenocarcinoma

This is a Phase Ⅲ, randomized, open-label, Sponsor-blinded, 3-arm, global, multicenter study assessing the efficacy and …

Anchorage, United StatesEst. completion Apr 27, 2029

Locally Advanced or Metastatic Malignant Solid Tumors

The primary purpose of this study is to determine the antitumor activity of enfortumab vedotin as measured by confirmed …

Tucson, United StatesEst. completion Feb 25, 2025

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.